Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis [PDF]
, 2012 Objective Systemic juvenile idiopathic arthritis (JIA) is characterized by fevers, rash, and arthritis, for which interleukin‐1 (IL‐1) and IL‐6 inhibitors appear to be effective treatments.
Carol A. Wallace +19 more
core +1 more source
Treatment failure by canakinumab in a patient with progressive multisystemic Erdheim–Chester disease refractory to anakinra: successful use of vemurafenib: Fig. 1 [PDF]
, 2015 Jan Henrik Schirmer +3 more
openalex +1 more source
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis [PDF]
, 2018 Background Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development.
Al-Hammadi, Noor +4 more
core +2 more sources
Pediatric Rheumatology Online JournalBackground Systemic juvenile idiopathic arthritis (sJIA) is a severe form of juvenile arthritis that is characterized by chronic joint inflammation and systemic symptoms such as fever, rash, and organ involvement.
Lingzhi Qiu +7 more
doaj +1 more source
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy [PDF]
, 2017 Arndt Brachat +25 more
openalex +1 more source
Jefferson Digital Commons quarterly report: October-December 2019 [PDF]
, 2019 This quarterly report includes: Articles Dean\u27s Research Development Lunch Conference Dissertations Educational Materials From the Archives Grand Rounds and Lectures Journals and Newsletters Population Health Presentation Materials Posters Reports ...
Copeland, LIBT, James +2 more
core +2 more sources
THE USE OF ANTI-IL1 (CANAKINUMAB) IN A CHILD WITH MEVALONIC ACIDURIA: A CASE REPORT [PDF]
, 2019 JÉSSICA APARECIDA FERNANDES +7 more
openalex +1 more source
MA03.10 The Interim Analysis of Can-Prevent-Lung Trial: Canakinumab for The Prevention of Lung Cancer [PDF]
, 2023 J. Zhang +22 more
openalex +1 more source
PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis [PDF]
, 2013 Ye Xiong +7 more
openalex +1 more source